Evaluation of effectiveness and safety for non-valvular atrial fibrillation patients who switched from warfarin to direct oral anticoagulants from multiple health care claims databases

Evaluation of effectiveness and safety for non-valvular atrial fibrillation patients who switched from warfarin to direct oral anticoagulants from multiple health care claims databases

Abstract Background: There is a paucity of real-world studies examining stroke/systemic embolism (S/SE) and major bleeding (MB) risks among non-valvular atrial fibrillation (NVAF) patients who switched from warfarin to a direct oral anticoagulant. Methods: A...
Evaluation of effectiveness and safety for non-valvular atrial fibrillation patients who switched from warfarin to direct oral anticoagulants from multiple health care claims databases

Association of sex with oral anticoagulant prescription and outcomes in patients with atrial fibrillation: Insights from a United States commercial claims database

Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the differential prescription patterns of OACs and outcomes in AF patients when categorized by male versus female sex. The primary objectives...
Evaluation of effectiveness and safety for non-valvular atrial fibrillation patients who switched from warfarin to direct oral anticoagulants from multiple health care claims databases

Association of age with oral anticoagulant prescription and outcomes in patients with atrial fibrillation: Insights from a United States commercial claims database

Abstract Background: Oral anticoagulants (OACs) reduce stroke risk in atrial fibrillation (AF) patients. Little is known about the prescription patterns of OAC prescription and outcomes in AF patients among different age groups. The primary objectives of this study...